# ACETAMINOPHEN AND IBUPROFEN
> **ANDA216999** · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2023-08-01
## Drug
- **FDA Application Number:** ANDA216999
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ACETAMINOPHEN AND IBUPROFEN
- **Generic name:** ACETAMINOPHEN AND IBUPROFEN
- **Active ingredients:** ACETAMINOPHEN; IBUPROFEN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** BIONPHARMA
- **Manufacturer:** AMERISOURCE BERGEN
- **First approval:** 2023-08-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216999)
---
*MORVS · CC0 1.0*